ISTOCK, ROBBIE ROSS
Gene Editing Reduces Monkeys’ Cholesterol
Gene Editing Reduces Monkeys’ Cholesterol
The results could lead to a treatment to lower cholesterol in patients with hypercholesterolemia.
Gene Editing Reduces Monkeys’ Cholesterol
Gene Editing Reduces Monkeys’ Cholesterol

The results could lead to a treatment to lower cholesterol in patients with hypercholesterolemia.

The results could lead to a treatment to lower cholesterol in patients with hypercholesterolemia.

genome editing
CRISPR Efficiency Tied to Cancer-Causing Process
CRISPR Efficiency Tied to Cancer-Causing Process
Kerry Grens | Jun 11, 2018
Two studies find the genome-editing technique works best when cells have a faulty DNA-damage response that’s frequently present in cancers.  
New Methods to Detect CRISPR Off-Target Mutations
New Methods to Detect CRISPR Off-Target Mutations
Sandeep Ravindran | Mar 1, 2018
Researchers have developed a variety of techniques to detect when CRISPR misses the mark.
Immunity May Make CRISPR-Based Therapies Ineffective
Immunity May Make CRISPR-Based Therapies Ineffective
Jim Daley | Jan 10, 2018
Researchers identify antibodies for two commonly used Cas9 proteins in human blood. Investors take notice.
Meet the Press, 1967
Meet the Press, 1967
Kerry Grens | Dec 1, 2017
Fifty years ago, Arthur Kornberg announced to reporters that his team had synthesized functional DNA.
2017 Top 10 Innovations
2017 Top 10 Innovations
The Scientist Staff | Dec 1, 2017
From single-cell analysis to whole-genome sequencing, this year's best new products shine on many levels.
Man Receives First In Vivo Gene-Editing Therapy
Man Receives First In Vivo Gene-Editing Therapy
Kerry Grens | Nov 15, 2017
The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.
RNA Editing Possible with CRISPR-Cas13
RNA Editing Possible with CRISPR-Cas13
Ruth Williams | Oct 25, 2017
Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells.
Base Editing Now Able to Convert Adenine-Thymine to Guanine-Cytosine
Base Editing Now Able to Convert Adenine-Thymine to Guanine-Cytosine
Catherine Offord | Oct 25, 2017
With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.
How Geneticists’ Views Compare to the Public’s on Genome Editing
How Geneticists’ Views Compare to the Public’s on Genome Editing
Bob Grant | Oct 22, 2017
Professionals in the genetics field generally support editing the genomes of somatic cells, mirroring public opinion, but diverge from nonexperts when it comes to germline editing.